AU734829B2 - Cyclopeptide derivatives - Google Patents

Cyclopeptide derivatives Download PDF

Info

Publication number
AU734829B2
AU734829B2 AU95319/98A AU9531998A AU734829B2 AU 734829 B2 AU734829 B2 AU 734829B2 AU 95319/98 A AU95319/98 A AU 95319/98A AU 9531998 A AU9531998 A AU 9531998A AU 734829 B2 AU734829 B2 AU 734829B2
Authority
AU
Australia
Prior art keywords
formula
compounds
acid
compound
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU95319/98A
Other languages
English (en)
Other versions
AU9531998A (en
Inventor
Simon Goodman
Gunter Holzemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU9531998A publication Critical patent/AU9531998A/en
Application granted granted Critical
Publication of AU734829B2 publication Critical patent/AU734829B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU95319/98A 1997-08-23 1998-08-14 Cyclopeptide derivatives Ceased AU734829B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19736772 1997-08-23
DE19736772A DE19736772A1 (de) 1997-08-23 1997-08-23 Cyclopeptidderivate
PCT/EP1998/005161 WO1999010371A2 (de) 1997-08-23 1998-08-14 Cyclopeptidderivate als adhäsionsinhibitoren

Publications (2)

Publication Number Publication Date
AU9531998A AU9531998A (en) 1999-03-16
AU734829B2 true AU734829B2 (en) 2001-06-21

Family

ID=7839977

Family Applications (1)

Application Number Title Priority Date Filing Date
AU95319/98A Ceased AU734829B2 (en) 1997-08-23 1998-08-14 Cyclopeptide derivatives

Country Status (18)

Country Link
EP (1) EP1007545A2 (id)
JP (1) JP2001514186A (id)
KR (1) KR20010022828A (id)
CN (1) CN1267306A (id)
AR (1) AR013650A1 (id)
AU (1) AU734829B2 (id)
BR (1) BR9811992A (id)
CA (1) CA2301182A1 (id)
DE (1) DE19736772A1 (id)
HU (1) HUP0003500A3 (id)
ID (1) ID23952A (id)
NO (1) NO20000860D0 (id)
PL (1) PL341090A1 (id)
RU (1) RU2200166C2 (id)
SK (1) SK2132000A3 (id)
TW (1) TW477793B (id)
WO (1) WO1999010371A2 (id)
ZA (1) ZA987558B (id)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA43823C2 (uk) * 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
JPH07316193A (ja) * 1994-05-24 1995-12-05 Asahi Glass Co Ltd ペプチド誘導体およびその用途

Also Published As

Publication number Publication date
JP2001514186A (ja) 2001-09-11
WO1999010371A3 (de) 1999-05-27
KR20010022828A (ko) 2001-03-26
HUP0003500A2 (hu) 2001-02-28
RU2200166C2 (ru) 2003-03-10
NO20000860L (no) 2000-02-22
NO20000860D0 (no) 2000-02-22
WO1999010371A2 (de) 1999-03-04
DE19736772A1 (de) 1999-02-25
TW477793B (en) 2002-03-01
AU9531998A (en) 1999-03-16
CA2301182A1 (en) 1999-03-04
SK2132000A3 (en) 2000-09-12
ID23952A (id) 2000-06-08
PL341090A1 (en) 2001-03-26
ZA987558B (en) 1999-02-23
BR9811992A (pt) 2000-09-05
EP1007545A2 (de) 2000-06-14
HUP0003500A3 (en) 2001-12-28
AR013650A1 (es) 2001-01-10
CN1267306A (zh) 2000-09-20

Similar Documents

Publication Publication Date Title
AU717574B2 (en) Cyclic adhesion inhibitors
US5849692A (en) Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
AU753333B2 (en) Diacylhydrazine derivatives as integrin inhibitors
AU697614B2 (en) Novel cyclopeptides for the preparation of medicaments
MXPA96004100A (en) Cyclic compounds, adhes inhibitors
AU717496B2 (en) Cyclic adhesion inhibitors
US5705481A (en) Cyclopeptides
ZA200105929B (en) α, β, integrin inhibitors.
AU733831B2 (en) Cyclic azapeptides
AU722817B2 (en) Cyclopeptide derivatives
AU734829B2 (en) Cyclopeptide derivatives
RU2129563C1 (ru) Циклопептиды или их соли, способ их получения, фармацевтические композиции и способ их получения, способ лечения
MXPA00001728A (en) Cyclopeptide derivatives as adhesion inhibitors
MXPA99011999A (en) Cyclic azapeptides with angiogenic effect
CZ2000636A3 (cs) Derivát cyklického peptidu jakožto inhibitor adheze
MXPA01000437A (en) Diacylhydrazine derivatives as integrin inhibitors
CZ465899A3 (cs) Derivát cyklického azapeptidu s angiogenním působením
MXPA99005778A (en) Cyclic peptide derivatives

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)